It will be carefully packed in an insulated shipping container with ice packs
Many patients can safely continue GLP-1 medications with appropriate precautions, but the decision depends on individual risk factors including dose escalation status, gastrointestinal symptoms, and type of surgery
The medication works by: Enhancing insulin secretion in a glucose-dependent manner, reducing the risk of hypoglycemia Suppressing glucagon release when blood glucose levels are elevated Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on central appetite regulation in the hypothalamus to decrease food intake Zepbound is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward (5 mg, 7.5 mg, 10 mg, 12.5 mg, to a maximum of 15 mg) based on individual tolerance and therapeutic response
Like GLP-1 receptor agonists, this medication also works by sending satiety signals to your brain to reduce appetite and delay gastric emptying